Innovative and accomplished Quality Systems Professional with a broad background in Pharmaceutical and Laboratory sciences with over 17 years industry practice. Overall background includes building and leading global teams across functions in the biotech and pharmaceutical space. She is passionate about continuous improvement activities and consistently building quality into each area of our lives by providing coaching, mentoring and professional support to team members, employees, and many others across industries who want to develop their leadership skills. Chair of Women in Quality group for the American Society for Quality, where she supports building the female leadership pipeline and building the future of success across various industries (automotive, aerospace, manufacturing, technology, etc.) Advocate and Gala Committee Member for the Tourette’s Association of America, Advocate for Make-A-Wish NJ and Powershift Ambassador for Shark Tank’s Daymond John.

Paul has been a statistician in the industry for over 25 years, working for Eli Lilly, GSK, Ipsen and AstraZeneca. His initial experiences were as a statistician on post-marketing studies and since then has slowly moved backwards through the phases to his current role in early clinical development.He has worked across most therapeutic areas and has specialized solely in oncology for the past 15 years. He joined AstraZeneca in 2012 and is now a Biometrics Team Leader in the Early Oncology Statistics team. He supports multiple different compounds in the oncology therapeutic area across many studies from Phase I up to Phase IIb. He has published on the AZ decision making framework and presented several times on the topic at conferences over the last few years.

Chrissie is the Vice President of Speciality and Primary Care Statistics at GSK. She has worked in the Pharmaceutical Industry for over 30 years and has experience of developing and commercialising new medicines in a variety of clinical disease areas across all phases of clinical development. Chrissie is actively engaged in statistical societies, pharmaceutical trade associations and initiatives relating to the Pharmaceutical Industry such as driving innovation in clinical trials and sharing implementation experiences of the estimand framework. She is an advocate and champion for diversity, equity and inclusion where she supports a variety of Women Leadership programs.